Literature DB >> 17178491

Treatment of experimental peri-implantitis using autogenous bone grafts and platelet-enriched fibrin glue in dogs.

Tae-Min You1, Byung-Ho Choi, Shi-Jiang Zhu, Jae-Hyung Jung, Seoung-Ho Lee, Jin-Young Huh, Hyun-Jung Lee, Jingxu Li.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the effects of autogenous bone grafts and platelet-enriched fibrin glue in the treatment of peri-implantitis. STUDY
DESIGN: Thirty-six screw-type commercially pure titanium implants with rough acid-etched surfaces were inserted into 6 mongrel dogs 3 months after extraction of mandibular premolars. After 3 months of healing, peri-implantitis was induced by placing gauze and wire around the implants. Once peri-implantitis was created, surgical treatments involving a combination of autogenous bone grafts and platelet-enriched fibrin glue, autogenous bone grafts alone, or a conventional flap procedure only (control) were carried out. Six months later, biopsies of the implant sites were taken and prepared for ground sectioning and analysis.
RESULTS: The amount of reosseointegration was significantly higher in peri-implantitis defects treated with combined autogenous bone grafts and platelet-enriched fibrin glue as compared with the other 2 treatment procedures. A mean bone-to-implant contact of 50.1% was obtained in the peri-implantitis lesions treated with combined autogenous bone grafts and platelet-enriched fibrin glue. The corresponding values for the autogenous bone grafts and control groups were 19.3% and 6.5%, respectively.
CONCLUSION: The present study demonstrates that surgical treatment involving the combined use of autogenous bone grafts and platelet-enriched fibrin glue might effectively promote reosseointegration in lesions resulting from peri-implantitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178491     DOI: 10.1016/j.tripleo.2006.01.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  8 in total

1.  Re-stability of dental implants following treatment of peri-implantitis.

Authors:  Fawad Javed; Hamza Ather Hussain; Georgios E Romanos
Journal:  Interv Med Appl Sci       Date:  2013-09-16

Review 2.  Pre-clinical models for oral and periodontal reconstructive therapies.

Authors:  G Pellegrini; Y J Seol; R Gruber; W V Giannobile
Journal:  J Dent Res       Date:  2009-11-03       Impact factor: 6.116

Review 3.  Effectiveness of Different Chemotherapeutic Agents for Decontamination of Infected Dental Implant Surface: A Systematic Review.

Authors:  Chayya Patil; Amit Agrawal; Shahabe Saquib Abullais; Suraj Arora; Shafait Ullah Khateeb; Mohamed Fadul A Elagib
Journal:  Antibiotics (Basel)       Date:  2022-04-28

4.  Reusing dental implants?: an experimental study for detecting the success rates of re-osseointegration.

Authors:  Murat Ulu; Erdem Kılıç; Emrah Soylu; Mehmet Kürkçü; Alper Alkan
Journal:  Int J Implant Dent       Date:  2018-06-19

5.  Aseptic Ligatures Induce Marginal Peri-Implant Bone Loss-An 8-Week Trial in Rabbits.

Authors:  David Reinedahl; Silvia Galli; Tomas Albrektsson; Pentti Tengvall; Carina B Johansson; Petra Hammarström Johansson; Ann Wennerberg
Journal:  J Clin Med       Date:  2019-08-18       Impact factor: 4.241

6.  D-arginine Enhances the Effect of Alpha-Amylase on Disassembling Actinomyces viscosus Biofilm.

Authors:  Baosheng Li; Qing Cai; Zixuan Wang; Shuwei Qiao; Yanzhen Ou; Rui Ma; Chuanfu Luo; Weiyan Meng
Journal:  Front Bioeng Biotechnol       Date:  2022-03-03

7.  Detoxification of implant surfaces affected by peri-implant disease: an overview of surgical methods.

Authors:  Pilar Valderrama; Thomas G Wilson
Journal:  Int J Dent       Date:  2013-08-04

8.  In vivo evaluation of an antibacterial coating containing halogenated furanone compound-loaded poly(l-lactic acid) nanoparticles on microarc-oxidized titanium implants.

Authors:  Yicheng Cheng; Bo Gao; Xianghui Liu; Xianghui Zhao; Weige Sun; Huifang Ren; Jiang Wu
Journal:  Int J Nanomedicine       Date:  2016-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.